We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+24.68%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.51B
AUM Growth
+$758M
Cap. Flow
+$605M
Cap. Flow %
17.25%
Top 10 Hldgs %
47.4%
Holding
285
New
108
Increased
67
Reduced
35
Closed
69

Top Buys

Rank Stock Value
1
IMDX
Insight Molecular Diagnostics
IMDX
+$28.2M
2
ALGN icon
Align Technology
ALGN
+$19.3M
3
APR
Apria, Inc. Common Stock
APR
+$17.3M
4
CUTR
Cutera, Inc.
CUTR
+$14.8M
5
CMIIU
CM Life Sciences II Inc. Unit
CMIIU
+$13M

Top Sells

Rank Stock Value
1
VCEL icon
Vericel Corp
VCEL
+$14.4M
2
AFIB
Acutus Medical Inc
AFIB
+$13.5M
3
SHC icon
Sotera Health
SHC
+$12.9M
4
OPCH icon
Option Care Health
OPCH
+$12.1M
5
BNGO icon
Bionano Genomics
BNGO
+$10.3M

Sector Composition

Rank Sector Weight
1 Healthcare 33%
2 Industrials 1.49%
3 Materials 0.46%
4 Financials 0.45%
5 Consumer Staples 0.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTRA icon
26
Natera
NTRA
$45.1B
$25.1M 0.72%
247,644
+45,144
+22% +$4.95M
DXCM icon
27
PUT
DexCom
DXCM
$33.8B
$24.3M 0.69%
270,000
+70,000
+35% +$6.57M
ILMN icon
28
PUT
Illumina
ILMN
$29.1B
$24M 0.68%
+64,250
New +$26.2M
ALXN
29
DELISTED
Alexion Pharmaceuticals
ALXN
$23.9M 0.68%
156,581
+32,685
+26% +$5.06M
RCM
30
DELISTED
R1 RCM Inc. Common Stock
RCM
$23.4M 0.67%
946,487
+34,647
+4% +$915K
APR
31
DELISTED
Apria, Inc. Common Stock
APR
$21.4M 0.61%
+766,712
New +$17.3M
VCEL icon
32
Vericel Corp
VCEL
$2.27B
$20.8M 0.59%
374,435
-317,380
-46% -$14.4M
LUNG icon
33
Pulmonx
LUNG
$97.1M
$20.3M 0.58%
442,896
+50,254
+13% +$2.88M
OM icon
34
Outset Medical
OM
$90.6M
$19.8M 0.56%
24,284
-9,277
-28% -$7.16M
PACB icon
35
Pacific Biosciences
PACB
$354M
$19.6M 0.56%
586,955
-189,075
-24% -$6.62M
XENT
36
DELISTED
Intersect ENT, Inc
XENT
$19M 0.54%
909,660
+53,937
+6% +$1.24M
ALGN icon
37
Align Technology
ALGN
$12.3B
$19M 0.54%
+35,000
New +$19.3M
LIVN icon
38
LivaNova
LIVN
$4.33B
$18.6M 0.53%
252,402
-6,401
-2% -$457K
ABT icon
39
PUT
Abbott
ABT
$190B
$18M 0.51%
+150,000
New +$17.8M
MDT icon
40
PUT
Medtronic
MDT
$116B
$17.7M 0.5%
+150,000
New +$17.6M
SIBN icon
41
SI-BONE Inc
SIBN
$843M
$17.5M 0.5%
550,104
-33,455
-6% -$1.03M
COO icon
42
CALL
Cooper Companies
COO
$15B
$17.5M 0.5%
+182,000
New +$17.3M
AMRS
43
DELISTED
Amyris Inc.
AMRS
$16.1M 0.46%
845,022
+495,022
+141% +$7.18M
NTLA icon
44
CALL
Intellia Therapeutics
NTLA
$1.68B
$15.9M 0.45%
+198,300
New +$13.3M
GH icon
45
Guardant Health
GH
$22.2B
$15.9M 0.45%
103,908
-50,184
-33% -$7.58M
ZBH icon
46
Zimmer Biomet
ZBH
$18.5B
$15.8M 0.45%
101,916
+14,003
+16% +$2.17M
PROF
47
Profound Medical
PROF
$254M
$15.5M 0.44%
771,593
-8,974
-1% -$215K
NTLA icon
48
Intellia Therapeutics
NTLA
$1.68B
$15.2M 0.43%
+190,000
New +$12.8M
EAR
49
PUT
DELISTED
Eargo, Inc. Common Stock
EAR
$15.2M 0.43%
+15,240
New +$17.4M
CUTR
50
DELISTED
Cutera, Inc.
CUTR
$15M 0.43%
+500,805
New +$14.8M
1
2
3 4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2021 Portfolio in Review

As of Q1 2021, Pura Vida Investments held 285 positions worth $3.51B, up 28% from $2.75B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Pura Vida Investments deployed $605M of net new capital in Q1 2021, opening 108 new positions and adding to 67 existing holdings. Its largest new stake was Align Technology: 35,000 shares worth $19M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Industrials and Materials.

On the sell side, the largest reduction was Vericel Corp, an estimated $14.4M trimmed.

  • Pura Vida Investments's largest Q1 2021 buy was Align Technology: 35,000 shares worth $19M.
  • Pura Vida Investments added most to Insight Molecular Diagnostics in Q1 2021, an estimated $28.2M increase.
  • Pura Vida Investments's biggest Q1 2021 reduction was Vericel Corp, cutting an estimated $14.4M.
  • Pura Vida Investments fully exited Acutus Medical Inc in Q1 2021, selling an estimated $13.5M.
  • Pura Vida Investments's ten largest holdings make up 47% of its $3.51B portfolio in Q1 2021.
  • Pura Vida Investments opened 108 new positions and closed 69 in Q1 2021.
  • Pura Vida Investments's portfolio value rose 28% quarter-over-quarter to $3.51B.

Based on Pura Vida Investments's 13F filing for Q1 2021, filed 12 May 2021.